ClassID:

94552

C07D241/54 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms Nitrogen atoms

Recent Application in this class:
#1
20240084102
2024-03-14

BISDIAMINOPHENYL COMPOUND, CROSSLINKING AGENT, COMPOSITION, AND MOLDED ARTICLE

#2
20230212523
2023-07-06

CULTURE MEDIUM FOR LARYNGEAL CANCER EPITHELIAL CELLS, CULTURE METHOD, AND APPLICATION THEREOF

#3
20210198216
2021-07-01

Heterocyclic compounds for the inhibition of PASK

#4
20180230108
2018-08-16

Heterocyclic compounds for the inhibition of PASK

#5
20170327512
2017-11-16

MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL

#6
20160229815
2016-08-11

Heterocyclic compounds for the inhibition of PASK

#7
20160222030
2016-08-04

Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders

#8
20150376198
2015-12-31

MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL

#9
20150266833
2015-09-24

Substituted pyrazines and a process for producing the same

#10
20150031679
2015-01-29

Heterocyclic compounds for the inhibition of PASK

#11
20140329257
2014-11-06

Detection of hydrogen peroxide

#12
20140206868
2014-07-24

Process for producing substituted benzo[F]imidazo[1,2-A]quinoxalin-3(11H)-ones

#13
20130190296
2013-07-25

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION

#14
20130045497
2013-02-21

Detection of hydrogen peroxide

#15
20120232272
2012-09-13

Process for producing benzo[]quinoxaline compounds

#16
20120165318
2012-06-28

Heterocyclic compounds for the inhibition of PASK

#17
20120094977
2012-04-19

Compositions and methods for the treatment of disease associated with TRP-P8 expression

#18
20100048540
2010-02-25

Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase Inhibitors

#19
20080234276
2008-09-25

Heterocyclic Triazines as Hypoxic Selective Protein Kinase Inhibitors

#20
20050182054
2005-08-18

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

#21
20050054651
2005-03-10

Compositions and methods for the treatment of disease associated with Trp-p8 expression